AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

COGSTATE LTD

1.305

+0.0100.77%

Volume:93.30K

Turnover:121.02K

Market Cap:221.17M

PE:19.72

High:1.360

Open:1.295

Low:1.270

Close:1.295

Loading ...

Overview Company News Filings

One Cogstate Insider Raised Their Stake In The Previous Year

Simply Wall St.

How these three core small cap holdings are tracking as sentiment swings

ASX Penny Stocks To Watch Under A$200M Market Cap

Simply Wall St.

Cogstate's (ASX:CGS) investors will be pleased with their stellar 249% return over the last five years

Simply Wall St.

Cogstate Limited Just Recorded A 9.5% Revenue Beat: Here's What Analysts Think

Simply Wall St.

Cogstate Ltd (COGZF) (H1 2025) Earnings Call Highlights: Record Revenue and Strategic ...

Cogstate Ltd H1 Pretax Profit USD 5.2 Million

THOMSON REUTERS

Cogstate Fiscal H1 Revenue Grows 19%; Shares Rise 5%

MT Newswires Live

Cogstate Ltd H1 Revenue USD 23.9 Million

THOMSON REUTERS

Cogstate Limited's (ASX:CGS) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Simply Wall St.

Cogstate Limited (ASX:CGS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Simply Wall St.

Returns At Cogstate (ASX:CGS) Are On The Way Up

Simply Wall St.

Cogstate to Start Share Buyback in November

MT Newswires Live

BRIEF-Cogstate Approves Share Buy- Back Of Up To 10%

Cogstate Ltd - Approved a Further on-Market Share Buy- Back of up to 10% of Cogstate's Issued Ordinary Share Capital

THOMSON REUTERS

Cogstate Insider Ups Holding During Year

Simply Wall St.

Cogstate Expands Alzheimer's Disease Leadership With Appointment of DR. Kaycee Sink, as Chief Medical Officer

THOMSON REUTERS

Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CGS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGS.AU\",,,,,undefined,":{"symbol":"CGS.AU","market":"AU","secType":"STK","nameCN":"COGSTATE LTD","latestPrice":1.305,"timestamp":1745302320000,"preClose":1.295,"halted":0,"volume":93299,"delay":0,"nameEN":"COGSTATE LTD","floatShares":85227845,"shares":169475783,"eps":0.06617802841475573,"marketStatus":"Closed","change":0.01,"latestTime":"04-22 16:12:00 AEST","open":1.295,"high":1.36,"low":1.27,"amount":121018,"amplitude":0.069498,"askPrice":1.35,"askSize":1807,"bidPrice":1.305,"bidSize":445,"shortable":3,"etf":0,"ttmEps":0.06617802841475573,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":1.295,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":1.112305,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGS.AU\",,,,,undefined,":{"symbol":"CGS.AU","floatShares":85227845,"roa":"10.74%","roe":"17.87%","lyrEps":0.049414,"volumeRatio":1.112305,"shares":169475783,"dividePrice":0,"high":1.36,"amplitude":0.069498,"preClose":1.295,"low":1.27,"week52Low":0.795,"pbRate":"3.21","psRate":"3.01","week52High":1.44,"institutionHeld":0,"latestPrice":1.305,"committee":-0.604796,"eps":0.06617802841475573,"divideRate":0,"volume":93299,"delay":0,"ttmEps":0.06617802841475573,"open":1.295,"prevYearClose":1.045,"prevWeekClose":1.295,"prevMonthClose":1.39,"prevQuarterClose":1.39,"fiveDayClose":1.27,"twentyDayClose":1.4,"sixtyDayClose":1.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526434259","title":"One Cogstate Insider Raised Their Stake In The Previous Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2526434259","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526434259?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:47","pubTimestamp":1744235255,"startTime":"0","endTime":"0","summary":"From what we can see, insiders were net buyers in Cogstate Limited's  during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.The Last 12 Months Of Insider Transactions At Cogstate. The Non-Executive Chairman Martyn Myer made the biggest insider purchase in the last 12 months. That single transaction was for AU$108k worth of shares at a price of AU$1.08 each. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of AU$1.27. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/one-cogstate-insider-raised-stake-214735719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7094","CGS.AU"],"gpt_icon":0},{"id":"2521413073","title":"How these three core small cap holdings are tracking as sentiment swings","url":"https://stock-news.laohu8.com/highlight/detail?id=2521413073","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521413073?lang=en_us&edition=fundamental","pubTime":"2025-03-20 12:58","pubTimestamp":1742446738,"startTime":"0","endTime":"0","summary":"While sentiment has changed quickly in just a month, the medium-term outlook for our small cap holdings remains positive. There is plenty of value out there if you look carefully and are willing to take a view longer than Trump’s next tweet.Given the recent half yearly reporting season just wrapped up, we felt it was worth providing an update on the core holdings that we’ve previously disclosed here on Livewire, as well as touch briefly on a few new stocks.Cuscal  reported its first result as a publicly listed company in February, stating they were on track to “meet or modestly exceed” FY25 guidance.Now management’s job is to keep hitting its targets and prove that consistent mid to high single digit volume growth can lead to low double digit EPS growth over the long term. If they can do this, we think the stock will move from trading at its current discount t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/how-these-three-core-small-cap-holdings-are-tracking-as-sentiment-swings","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/how-these-three-core-small-cap-holdings-are-tracking-as-sentiment-swings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["SMP.AU","BK7033","XJO.AU","BK4588","BK4142","BK7500","XKO.AU","BK4585","XAO.AU","BK4517","BK7088","BK4547","EGL.AU","CCL.AU","BK7158","TYR.AU","BK7094","CCL","CGS.AU"],"gpt_icon":0},{"id":"2518519702","title":"ASX Penny Stocks To Watch Under A$200M Market Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2518519702","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518519702?lang=en_us&edition=fundamental","pubTime":"2025-03-10 10:05","pubTimestamp":1741572304,"startTime":"0","endTime":"0","summary":"After a turbulent Week 10, the Australian share market is poised for a rebound, with the ASX 200 expected to climb back over 8,000 points. In such fluctuating conditions, identifying stocks with strong financial foundations becomes crucial. While 'penny stocks' may seem like an outdated term, they still hold potential for growth and value discovery in smaller or newer companies.Overview: Alkane Resources Ltd is an Australian company focused on gold exploration and production, with a market capitalization of A$381.49 million.Alkane Resources, with a market cap of A$381.49 million, focuses on gold exploration and production. Recent earnings for the half year ended December 2024 show sales of A$121.5 million and net income of A$13.16 million, indicating growth compared to the previous year. Despite no debt concerns and seasoned management, challenges include lower profit margins  and insufficient short-term assets to cover liabilities . The company's stock trades significantly below its e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-penny-stocks-watch-under-020504323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7055","SHA.AU","BK7129","BIS.AU","BK7506","XJO.AU","BK7045","XAO.AU","WAF.AU","BK7048","CGS.AU","BK7095","XKO.AU","IGL.AU","CLX.AU","GTN.AU","BK7507","EZZ.AU","MLX.AU","BK7094","BK7058","BK7021","BK7062","ALK.AU","AX1.AU","GNG.AU","RPL.AU","BK7104"],"gpt_icon":0},{"id":"2518251972","title":"Cogstate's (ASX:CGS) investors will be pleased with their stellar 249% return over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2518251972","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518251972?lang=en_us&edition=fundamental","pubTime":"2025-03-10 09:54","pubTimestamp":1741571644,"startTime":"0","endTime":"0","summary":"When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on a lighter note, a good company can see its share price rise well over 100%. For instance, the price of Cogstate Limited  stock is up an impressive 249% over the last five years. Also pleasing for shareholders was the 18% gain in the last three months. This could be related to the recent financial results, released recently - you can catch up on the most recent data by reading our company report.So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share  with the share price.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogstates-asx-cgs-investors-pleased-015404592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7094","CGS.AU"],"gpt_icon":0},{"id":"2513175382","title":"Cogstate Limited Just Recorded A 9.5% Revenue Beat: Here's What Analysts Think","url":"https://stock-news.laohu8.com/highlight/detail?id=2513175382","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513175382?lang=en_us&edition=fundamental","pubTime":"2025-02-22 04:34","pubTimestamp":1740170073,"startTime":"0","endTime":"0","summary":"Shareholders of Cogstate Limited  will be pleased this week, given that the stock price is up 19% to AU$1.40 following its latest half-yearly results. Results overall were respectable, with statutory earnings of US$0.031 per share roughly in line with what the analyst had forecast. Revenues of US$23m came in 9.5% ahead of analyst predictions. The analyst typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimate suggests is in store for next year.Another thing to consider is whether management and directors ha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogstate-limited-just-recorded-9-203433156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CGS.AU"],"gpt_icon":0},{"id":"2512494342","title":"Cogstate Ltd (COGZF) (H1 2025) Earnings Call Highlights: Record Revenue and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2512494342","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512494342?lang=en_us&edition=fundamental","pubTime":"2025-02-20 15:12","pubTimestamp":1740035577,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Cogstate Ltd  reported a record revenue result for the first half of the 2025 financial year, with total revenue of $23.9 million, up 19% from the previous corresponding period.The company achieved a significant improvement in gross profit margin, up 2.5 points from the most recent half and 7 points compared to the previous corresponding period.Cogstate Ltd  has established a promising partnership with Medidata, which has already resulted in a phase 2 influenza trial award and a strong initial pipeline of opportunities.A: Unidentified_2 : The trend is not about shrinking lead times but rather a change in the mix of indications. Smaller trials with shorter durations lead to quicker revenue recognition. This trend is expected to continue as Cogstate supports more opportunities through channel partners like Medidata. U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogstate-ltd-cogzf-h1-2025-071257043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["COGZF","DASTF","CGS.AU","DASTY"],"gpt_icon":0},{"id":"2512437663","title":"Cogstate Ltd H1 Pretax Profit USD 5.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2512437663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512437663?lang=en_us&edition=fundamental","pubTime":"2025-02-20 05:42","pubTimestamp":1740001323,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nPLX098185:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGS.AU","BK7094"],"gpt_icon":0},{"id":"2504944069","title":"Cogstate Fiscal H1 Revenue Grows 19%; Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504944069","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504944069?lang=en_us&edition=fundamental","pubTime":"2025-01-20 13:00","pubTimestamp":1737349222,"startTime":"0","endTime":"0","summary":"Cogstate  said that for the fiscal half ended Dec. 31, 2024, it reported total revenue of about AU$23.9 million, an increase of 19% from AU$20.2 million a year earliere, according to a Monday filing with the Australian bourse.Clinical trials revenue rose 27% to about AU$22.7 million over the same period. Net clinical trials sales contracts executed clocked in at AU$20.3 million, a growth of 86% from the prior corresponding half-year.It also bought back 1.4 million ordinary shares for a total cost of AU$1.6 million, at an average cost of AU$1.12 per share.The firm's shares rose almost 5% in recent trading on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CGS.AU"],"gpt_icon":0},{"id":"2504497175","title":"Cogstate Ltd H1 Revenue USD 23.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2504497175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504497175?lang=en_us&edition=fundamental","pubTime":"2025-01-20 05:23","pubTimestamp":1737321791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250119:nPLXF7BD56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","CGS.AU"],"gpt_icon":0},{"id":"2500614939","title":"Cogstate Limited's (ASX:CGS) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?","url":"https://stock-news.laohu8.com/highlight/detail?id=2500614939","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500614939?lang=en_us&edition=fundamental","pubTime":"2025-01-02 09:20","pubTimestamp":1735780803,"startTime":"0","endTime":"0","summary":"Most readers would already know that Cogstate's  stock increased by 8.3% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be paying attention to Cogstate's  ROE today.Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Simply put, it is used to assess the profitability of a company in relation to its equity capital.Return on Equity = Net Profit  ÷ Shareholders' Equity. As a next step, we compared Cogstate's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 13%.Given that Cogstate doesn't pay any regular dividends to its shareholders, we infer that the company has been reinvesting all of its profits to grow its business.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogstate-limiteds-asx-cgs-recent-012003437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7094","CGS.AU"],"gpt_icon":0},{"id":"2491471511","title":"Cogstate Limited (ASX:CGS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2491471511","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491471511?lang=en_us&edition=fundamental","pubTime":"2024-12-15 06:02","pubTimestamp":1734213751,"startTime":"0","endTime":"0","summary":"The Cogstate Limited ( ASX:CGS ) share price has done very well over the last month, posting an excellent gain of 27...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/cogstate-limited-asxcgs-stock-rockets-27-as-investors-are-le","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1147","ISBC","CGS.AU","06881","BK7094","BK4211","BK1564"],"gpt_icon":0},{"id":"2481691116","title":"Returns At Cogstate (ASX:CGS) Are On The Way Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2481691116","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481691116?lang=en_us&edition=fundamental","pubTime":"2024-11-08 04:01","pubTimestamp":1731009715,"startTime":"0","endTime":"0","summary":"What trends should we look for it we want to identify stocks that can multiply in value over the long term?Amongst other things, we'll want to see two things; firstly, a growing return on capital employed  and secondly, an expansion in the company's amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. So when we looked at Cogstate  and its trend of ROCE, we really liked what we saw.Return On Capital Employed : What Is It?If you haven't worked with ROCE before, it measures the 'return'  a company generates from capital employed in its business. Analysts use this formula to calculate it for Cogstate:. Return on Capital Employed = Earnings Before Interest and Tax  ÷ . Thus, Cogstate has an ROCE of 14%.  In absolute terms, that's a satisfactory return, but compared to the Healthcare Services industry average of 8.7% it's much better.ASX:CGS Return on Capital Employed Novemb","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/returns-cogstate-asx-cgs-way-200155184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["EBIT","BK7094","CGS.AU"],"gpt_icon":0},{"id":"2477028759","title":"Cogstate to Start Share Buyback in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2477028759","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477028759?lang=en_us&edition=fundamental","pubTime":"2024-10-21 09:33","pubTimestamp":1729474388,"startTime":"0","endTime":"0","summary":"Cogstate  will start its 12-month on-market share buyback program on Nov. 11.The neuroscience technology company will repurchase up to 17.3 million shares, or 10% of its issued ordinary shares, according to Monday filings with the Australian bourse.The company's shares were up almost 2% in recent Monday trade.Price : $0.93, Change: $+0.02, Percent Change: +1.65%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","CGS.AU","XKO.AU","XJO.AU","AUD","XAO.AU","BK4125"],"gpt_icon":0},{"id":"2477004903","title":"BRIEF-Cogstate Approves Share Buy- Back Of Up To 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477004903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477004903?lang=en_us&edition=fundamental","pubTime":"2024-10-21 08:29","pubTimestamp":1729470584,"startTime":"0","endTime":"0","summary":"Oct 21 (Reuters) - CogState Ltd   :   * APPROVED A FURTHER ON-MARKET SHARE BUY- BACK OF UP TO 10% OF COGSTATE'S ISSUED ORDINARY SHARE CAPITALFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","CGS.AU"],"gpt_icon":0},{"id":"2477015356","title":"Cogstate Ltd -  Approved a Further on-Market Share Buy- Back of up to 10% of Cogstate's Issued Ordinary Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2477015356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477015356?lang=en_us&edition=fundamental","pubTime":"2024-10-21 05:25","pubTimestamp":1729459552,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241020:nFWN3LV03B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGS.AU","BK7094"],"gpt_icon":0},{"id":"2475883959","title":"Cogstate Insider Ups Holding During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2475883959","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475883959?lang=en_us&edition=fundamental","pubTime":"2024-10-16 13:29","pubTimestamp":1729056576,"startTime":"0","endTime":"0","summary":"From what we can see, insiders were net buyers in Cogstate Limited's  during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogstate-insider-ups-holding-during-052936681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CGS.AU","BK7094"],"gpt_icon":0},{"id":"2475396290","title":"Cogstate Expands Alzheimer's Disease Leadership With Appointment of DR. Kaycee Sink, as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2475396290","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475396290?lang=en_us&edition=fundamental","pubTime":"2024-10-14 23:15","pubTimestamp":1728918901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241014:nTUA4QLND3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGS.AU","BK7094"],"gpt_icon":0},{"id":"2475995003","title":"Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2475995003","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475995003?lang=en_us&edition=fundamental","pubTime":"2024-10-14 23:14","pubTimestamp":1728918840,"startTime":"0","endTime":"0","summary":"Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024  -- Cogstate, a leading neuroscience technology company, today announced the appointment of Kaycee Sink, MD, MAS, as Chief Medical Officer. In this role, Dr. Sink will lead Cogstate’s support of clinical trials in Alzheimer’s disease and other neurodegenerative disorders, including the advancement of new innovations to improve data quality and trial efficiency for more accurate conclusive studies.Dr. Sink will use her extensive experience in Alzheimer’s disease drug development—gained from leading global trials and programs—to advise biopharmaceutical leaders through strategic trial design decisions, endpoint selection, and data quality considerations for cognitive and clinical outcome assessments.Dr. Sink will also play a critical role in Cogstate’s efforts to commercialize cognitive assessment technologies within the community to support timely and more accurate diagnoses in healthcare.About CogstateCogstate Ltd  is a leadi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/iE5Je.6wZjtu87wuyfyFww--~B/aD0yMjU7dz0yMjU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f6845bbc535ce437b5435eab0aeb1d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/iE5Je.6wZjtu87wuyfyFww--~B/aD0yMjU7dz0yMjU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f6845bbc535ce437b5435eab0aeb1d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogstate-expands-alzheimers-disease-leadership-151400431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CGS.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGS.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-20","symbol":"CGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null},{"date":"2024-08-22","symbol":"CGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724284800000,"name":null,"time":"","dateTimestamp":1724248800000,"actualEps":null},{"date":"2024-02-22","symbol":"CGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-08-22","symbol":"CGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692662400000,"name":null,"time":"","dateTimestamp":1692626400000,"actualEps":null},{"date":"2023-02-28","symbol":"CGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677538800000,"name":null,"time":"","dateTimestamp":1677502800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGS.AU\",market:\"AU\",,,undefined,":[]}}